Pfizer faces another year of revenue decline in 2026, as Covid and loss-of-exclusivity headwinds weigh on top line growth.
The Supreme Court ruled Tuesday to keep a lower court's ruling in place, temporarily barring President Donald Trump from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback